MRI contrast developer Epix Medical of Cambridge, MA, reported that the underwriters of its recent public offering of 4.3 million shares of common stock have purchased an additional 345,000 shares as part of an overallotment option in connection with the offering. The completion of the offering, including exercise of the overallotment option, resulted in the total sale of 4.6 million shares, with proceeds to the company, after underwriting discounts, of $65.8 million, Epix said.
By AuntMinnie.com staff writersAugust 27, 2003
Related Reading
Epix sets share price, August 7, 2003
Epix to offer more shares, July 28, 2003
Epix shows slight revenue increase, lower loss in Q2, July 25, 2003
Epix completes final phase III trials on MRA contrast agent, July 11, 2003
Epix, Schering to partner on MRI contrast, May 27, 2003
Copyright © 2003 AuntMinnie.com
